Ibrutinib racemate is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
Molecular Weight
440.5
Molecular Formula
C25H24N6O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Ibrutinib racemate is a BTK inhibitor analyzed for its broad-spectrum activity against B-cell malignancies.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
